ILSI-Biomed Israel

2P2D Ltd. Announces the Appointment of Tovi Bachar, Former Managing Director of GE Healthcare Israel, as Director and Chairman

TEL AVIV, Israel, Feb. 8, 2011 /PRNewswire/ - 2P2D Ltd., a medical device company developing telemedicine systems for clinical trial management, today announced that it has appointed Mr. Tovi Bachar, former Managing Director of GE Healthcare Israel, as Director and Chairman. Tovi Bachar has completed seven years as Managing Director of GE Healthcare Israel, a subsidiary of GE Medical Systems, a leading diagnostic imaging equipment company. In 2008, Tovi Bachar was awarded the Managing Dir...

FDAnews Virtual Conference: Complying with FDA’s Unique Device Identification Rule; Feb 24 2011

The soon-to-be-issued FDA proposed rule requiring adoption of Unique Device Identification (UDI) has device manufacturers in a sweat. But an upcoming virtual conference for medical device companies promises to shed light. The FDA is about to unveil a proposed rule that could dramatically increase the volume and type of information you supply to the FDA. The new rule will require you to create a unique ID and label for every product that carries risk. The label will include name of manu...

Teva’s layoff at its Irvine facility

Teva Pharmaceuticals Inc. , an Irvine drug maker, will cut 200 jobs this year, including 195 as of Feb. 6, the company confirmed. “Our Irvine, California facility has been under a voluntary manufacturing and distribution hold since April 2010,” said Denise Bradley, Teva spokeswoman in a company statement. “Prior to this reduction, we have not laid off any employees as a result of this voluntary production hold. The jobs which are being eliminated are all various production jobs and support st...

A free webinar “Medical Technology Innovation scorecard: The race for global leadership”.

ILSI is announcing a webinar by Dr. Chris Wasden titled “Medical Technology Innovation scorecard: The race for global leadership”. It will take place on January 25th at 17:00 and is free to all. If you are interested, please register through sima@ilsi.org.il or Michal@ilsi.org.il or use ILSI telephone numbers 03-600-5008/5118. Dr. Chris Wasden Dr. Christopher Wasden is a managing director leading PwC's strategy and innovation practice focused on the healthcare industry. He is a named i...

The 2011 US-Israel Venture Summit

The US/Israel Venture Summit, presented by youngStartup Ventures, is the premier gathering where cutting-edge Israeli startups meet top venture capitalists, angel investors, Corporate VCs and investment bankers from throughout North America. It will be held at March 29-30, 2011. Whether you are an investor seeking new deals, or an emerging company seeking capital and exposure, the The US/Israel Venture Summit, is one event you won’t want to miss. Now in its 5th year, this productive fu...

BioView Ltd. Ranked in Top 50 Fastest Growing Israeli Technology Companies in Deloitte Survey

BioView Ltd. (TASE:BIOV) announced that it ranked as one of the 50 fastest growing technology companies in Israel. The Deloitte Technology Fast 50, one of the Israel's foremost technology award programs, is a ranking of the country's 50 fastest-growing technology companies based on percentage growth over five years. The Fast 50 program honors business growth, technological innovation and Israel entrepreneurial spirit. BioView’s automated scanning microscope and image analysis systems...

BioCancell Announces Success in Pre-Clinical Trial of New Therapy BC-821 on Glioblastoma

BioCancell Therapeutics, Inc. has successfully completed pre-clinical animal studies, using mice, that examined the use of BioCancell's new product candidate BC-821 as a treatment for glioblastoma (the most common and agressive type of primary human brain tumor). The research, carried out by Dr. Doron Amit in the Hebrew University laboratory of Prof. Abraham Hochberg, BioCancell's founder and chief scientist, showed that BC-821 succeeded in significantly inhibiting brain tumor volume growth in a...

From Haifa to Herzliya, the Fertile Ground of Israeli Innovation

What do website gadget developer LabPixies and insulin pump maker Medingo have in common? It's not only that both companies are based in Israel. They also are among the country's start-ups that have attracted the attention of international investors, with U.S. Internet giant Google recently snapping up LabPixies and Swiss pharmaceutical multinational Roche buying Medingo, a subsidiary of local medical device conglomerate Elron Electronic Industries. Israel is indeed becoming fertile ground for t...

Second Webinar in the series of REIMBURSEMENT Offered by top USA Consultants and PAID BY ILSI

The US reimbursement environment is changing for medical devices and pharmaceuticals. Understanding and building plans to maximize coverage and payment across the diverse US payer landscape and gaining access to US payers is a critical hurdle for Israeli technology companies. And few ex-US technology companies are prepared for this market. Failure to prepare can – and frequently does – lead to failure to commercialize technology, or significant loss of value on exit. To help Israeli comp...

Syneron Medical Ltd (ELOS) Acquires Pharos Life Corporation For Up to $15.75M

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced at December, 8 that it has acquired privately-held Pharos Life Corporation, a leading manufacturer of home-use light therapy for aesthetic procedures. Pharos Life Corporation's products are marketed directly to consumers through premium retailers under the Tהnda™ brand name and include products for skincare and wellness solutions for both the home-use and professional markets. Under terms of the ag...